Pharmafile Logo

Patient outcomes in practice: delivering value that transforms lives

June 11, 2018 |  

- PMLiVE
In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’.

In response to the increasing demands of global healthcare systems, pharma must demonstrate its value contribution. It is responding with patient-centric corporate missions, and patient outcomes-driven visions and initiatives, all with the aim of improving patient outcomes.

Dennis and Louise discuss how it’s no longer good enough to prove a commitment to patient outcomes, but instead we must demonstrate an impact. The programmes and initiatives that are incorporated into cross-functional plans all need to align to the same goal – so that we can then measure their impact against improving patient outcomes.

The vision is there, but it requires translation of this vision to execution of outcomes-led strategic planning, cross-functional alignment and metrics collection that transcend annual key performance indicator cycles. You can read more in the full article here

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group sets the vision for its team of committed Mental Health First Aiders

As we approach World Mental Health Day, Lucid's team of Mental Health First Aiders reflect on their training and set the vision for how they will be supporting the organisation...

The Lucid Group Wellbeing Champions embark on their MHFA training

A mentally sound organisation is good for talent and business. Statistics from Mental Health First Aid (MHFA) England point out to mental health illness (such as depression or anxiety) accounting...

Lucid Group Nurtures Talent. Always.

Lockdown and Covid-19 have not stopped us from nurturing and developing the amazing talent we have at Lucid. Growth is at the heart of #LucidLife.So if you're looking for a place...

Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards

Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in...

It’s been ten magical years at Lucid Group for Emma Cox

August marks a special work anniversary for Emma Cox who is celebrating 10 years at Lucid Group!Over the past decade, Emma has demonstrated resilience, tenacity and grit with a disarming...

Lucid Group: Digital Delivery in Lockdown

Standing still is the fastest way of moving backwards in today's world. That's why we've been moving forward and transforming at every step to make sure we can continue to...

Lucid Group scoop a win and a high commendation at Communiqué 2020

Due to the COVID-19 pandemic, this year’s Communiqué awards was a virtual ceremony, celebrating some of the most inspiring work and people in medical communications.Lucid Group were delighted to come...

PHARMA POST COVID-19: REVOLUTION OR EVOLUTION?

Post-COVID-19 thinking: outputs from a thought leader forumOn 14 May 2020, a group of industry experts across pharma and biotech Zoomed together to share reflections on the impact of COVID-19...

Lucid Group are shortlisted in three categories for Communiqué 2020

Lucid’s talent for creating industry-leading programmes is clear to see as they celebrate three of its campaigns being shortlisted for Communiqué 2020, as well as making the finals forThe Real...

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

In this month’s Smart Thinking blog on PMLive.com, Stephanie Wasek, now a permanent principal medical writer at Lucid Group, draws her experience to discuss the highs and lows of being...